Abstract:
The present invention relates to a pharmaceutical composition for photodynamic treatment of a fungal skin disorder, said pharmaceutical composition comprising a photosensitizer and an enhancer, wherein the photosensitizer is a cationic photosensitizer and the enhancer is chosen from the group of i) an acid, and ii) a metal chelating agent. Such a composition is capable of eliminating both conidiae and hy- phae. The invention also relates to a method for the preparation of the pharmaceutical composition.
Abstract:
The present invention relates to a pharmaceutical composition for photodynamic treatment of a fungal skin disorder, said pharmaceutical composition comprising a photosensitizer and an enhancer, wherein the photosensitizer is a cationic photosensitizer and the enhancer is chosen from the group of i) an acid, and ii) a metal chelating agent. Such a composition is capable of eliminating both conidiae and hy-phae. The invention also relates to a method for the preparation of the pharmaceutical composition.
Abstract:
Una composición farmacéutica para el tratamiento fotodinámico de un trastorno fúngico de la piel, comprendiendo dicha composición farmacéutica un fotosensibilizante y un potenciador, en el que el fotosensibilizante comprende un macrociclo de porfirina que comprende al menos un átomo de nitrógeno cuaternizado, siendo el potenciador un ácido, y presentando la composición farmacéutica un pH de x en el que 3,5
Abstract:
The present invention relates to a pharmaceutical composition for photodynamic treatment of a fungal skin disorder, said pharmaceutical composition comprising a photosensitizer and an enhancer, wherein the photosensitizer is a cationic photosensitizer and the enhancer is chosen from the group of i) an acid, and ii) a metal chelating agent. Such a composition is capable of eliminating both conidiae and hy-phae. The invention also relates to a method for the preparation of the pharmaceutical composition.